The ability to predict well in advance could allow for early intervention and prevention. Researchers have discovered five ...

New findings to be presented at the 2025 European Association for the Study of the Liver (EASL) Congress continue to demonstrate the effectiveness of Livdelzi (seladelpar) in reducing pruritus in ...

To report SUSPECTED ADVERSE REACTIONS, contact Intercept Pharmaceuticals, Inc. at 1-844-782-ICPT or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

A new online petition is calling for a change to eligibility rules for Personal Independence Payment (PIP). At present, people making a new claim for PIP must be able to demonstrate that the ...

As robotic cholecystectomy, also known as gallbladder removal, becomes increasingly common, researchers have identified ...

Ipsen Biopharmaceuticals Canada Inc. today announced Health Canada has issued a Notice of Compliance with Conditions (NOC/c) approving IQIRVO® (elafibranor) for the treatment of primary biliary ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion ...

Globally, a significant portion of adults are affected by fatty liver disease, often linked with vitamin D deficiency. The ...